melanoma brain metastases research hub

A phase II, open label, randomised trial of ipilimumab and nivolumab with concurrent intracranial stereotactic radiotherapy versus ipilimumab and nivolumab alone in patients with melanoma brain metastases

This study looks at combining two existing cancer drugs, YERVOY and OPDIVO, with or without special radiation therapy for people with melanoma that has spread to the brain. It aims to see how well this combination works.